724098 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Effect of zinc oxide nanoparticles and ferulic acid on renal ischemia/reperfusion injury: possible underlying mechanisms |
2021-08-01 |
10.1016/j.biopha.2021.111686 |
Awadalla Amira, Hussein Abdelaziz M., El-Far Yousra M., Barakat Nashwa, Hamam Eman T., El-Sherbiny Mohamed, El-Shafey Mohamed, Shokeir Ahmed A. |
724097 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Resveratrol significantly improves cell survival in comparison to dexrazoxane and carvedilol in a h9c2 model of doxorubicin induced cardiotoxicity |
2021-08-01 |
10.1016/j.biopha.2021.111702 |
Monahan David S., Flaherty Eimhear, Hameed Aamir, Duffy Garry P. |
724096 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Emerging role of lncRNAs in the regulation of Rho GTPase pathway |
2021-08-01 |
10.1016/j.biopha.2021.111731 |
Ghafouri-Fard Soudeh, Noroozi Rezvan, Abak Atefe, Taheri Mohammad, Salimi Alireza |
724095 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Mdivi-1, a mitochondrial fission inhibitor, reduces angiotensin-II- induced hypertension by mediating VSMC phenotypic switch |
2021-08-01 |
10.1016/j.biopha.2021.111689 |
Deng Yue, Li Shuangyue, Chen Zhenzhen, Wang Wenjie, Geng Bin, Cai Jun |
724094 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Bifidobacterium reduction is associated with high blood pressure in children with type 1 diabetes mellitus |
2021-08-01 |
10.1016/j.biopha.2021.111736 |
Lakshmanan Arun Prasath, Shatat Ibrahim F., Zaidan Sara, Jacob Shana, Bangarusamy Dhinoth Kumar, Al-Abduljabbar Shaikha, Al-Khalaf Fawziya, Petroviski Goran, Terranegra Annalisa |
724093 |
BIOMEDICINE & PHARMACOTHERAPY = BIOMÉDECINE & PHARMACOTHÉRAPIE |
Pioglitazone rescues high-fat diet-induced depression-like phenotypes and hippocampal astrocytic deficits in mice |
2021-08-01 |
10.1016/j.biopha.2021.111734 |
Lam Ying-Yiu, Tsai Sheng-Feng, Chen Pei-Chun, Kuo Yu-Min, Chen Yun-Wen |
724092 |
ENDOCRINE-RELATED CANCER |
Celebrating the 80th anniversary of hormone ablation for prostate cancer |
2021-08-01 |
10.1530/erc-21-0192 |
Zoubeidi Amina, Ghosh Paramita M |
724091 |
ENDOCRINE-RELATED CANCER |
Second-generation hormonotherapy in prostate cancer and bone microenvironment |
2021-08-01 |
10.1530/erc-21-0118 |
Bouleftour Wafa, Boussoualim Karima, Sotton Sandrine, Vassal Cecile, Thomas Thierry, Magne Nicolas, Guillot Aline |
724090 |
ENDOCRINE-RELATED CANCER |
Targeting androgen receptor signaling: a historical perspective |
2021-08-01 |
10.1530/erc-21-0116 |
Davies Alastair H, Zoubeidi Amina |
724089 |
ENDOCRINE-RELATED CANCER |
Management of early-stage metastatic prostate cancer: appraisal of locoregional treatments and radiation therapy, with or without immunomodulation |
2021-08-01 |
10.1530/erc-21-0073 |
Sandoval Maria L, Dohm Ammoren, Yamoah Kosj |